Total Payments
$4,512
2024 Payments
$33.84
Companies
5
Transactions
15
Medicare Patients
4,367
Medicare Billing
$262,156
Payment Breakdown by Category
Consulting$3,200 (70.9%)
Travel$918.13 (20.3%)
Food & Beverage$394.00 (8.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,200 | 1 | 70.9% |
| Travel and Lodging | $918.13 | 5 | 20.3% |
| Food and Beverage | $394.00 | 9 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $4,435 | 10 | $0 (2019) |
| ABBVIE INC. | $37.11 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $17.90 | 1 | $0 (2024) |
| PFIZER INC. | $12.01 | 1 | $0 (2022) |
| Novo Nordisk Inc | $10.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.84 | 2 | Phathom Pharmaceuticals, Inc. ($17.90) |
| 2023 | $21.17 | 1 | ABBVIE INC. ($21.17) |
| 2022 | $12.01 | 1 | PFIZER INC. ($12.01) |
| 2019 | $4,406 | 9 | Amgen Inc. ($4,406) |
| 2018 | $38.77 | 2 | Amgen Inc. ($28.27) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: VACCINES | ||||||
| 07/31/2019 | Amgen Inc. | — | Travel and Lodging | Cash or cash equivalent | $95.04 | General |
| 07/31/2019 | Amgen Inc. | — | Food and Beverage | Cash or cash equivalent | $14.88 | General |
| 06/06/2019 | Amgen Inc. | Prolia (Biological) | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| Category: Bone Health | ||||||
| 05/18/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $148.84 | General |
| Category: Bone Health | ||||||
| 05/18/2019 | Amgen Inc. | Prolia (Biological) | Travel and Lodging | In-kind items and services | $47.10 | General |
| Category: Bone Health | ||||||
| 05/17/2019 | Amgen Inc. | Prolia (Biological) | Travel and Lodging | In-kind items and services | $403.49 | General |
| Category: Bone Health | ||||||
| 05/17/2019 | Amgen Inc. | Prolia (Biological) | Travel and Lodging | In-kind items and services | $258.75 | General |
| Category: Bone Health | ||||||
| 05/17/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $124.49 | General |
| Category: Bone Health | ||||||
| 05/17/2019 | Amgen Inc. | Prolia (Biological) | Travel and Lodging | In-kind items and services | $113.75 | General |
| Category: Bone Health | ||||||
| 06/21/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Endocrinology | ||||||
| 04/09/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,120 | 1,595 | $202,676 | $63,042 |
| 2022 | 15 | 1,051 | 1,473 | $204,971 | $57,873 |
| 2021 | 16 | 1,207 | 1,585 | $163,844 | $75,629 |
| 2020 | 16 | 989 | 1,402 | $171,590 | $65,612 |
Total Patients
4,367
Total Services
6,055
Medicare Billing
$262,156
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 326 | $57,140 | $14,016 | 24.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 235 | $26,920 | $9,409 | 35.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $6,930 | $4,795 | 69.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 58 | 60 | $4,650 | $4,521 | 97.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 177 | 177 | $40,002 | $3,681 | 9.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 61 | $10,245 | $3,600 | 35.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 231 | 415 | $4,565 | $3,452 | 75.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 26 | 35 | $8,247 | $2,933 | 35.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 33 | $6,618 | $2,930 | 44.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 22 | $8,986 | $2,718 | 30.3% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 19 | 19 | $2,774 | $2,574 | 92.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 31 | $9,888 | $2,070 | 20.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $4,947 | $1,936 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 62 | 64 | $2,368 | $1,830 | 77.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 15 | $6,466 | $896.22 | 13.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 19 | 19 | $760.00 | $686.16 | 90.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $540.00 | $486.20 | 90.0% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 11 | 12 | $480.00 | $457.44 | 95.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 15 | $150.00 | $51.15 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 336 | $57,792 | $16,623 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 143 | 203 | $22,736 | $8,516 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $33,900 | $5,849 | 17.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 37 | 56 | $27,250 | $4,230 | 15.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 24 | $10,551 | $3,417 | 32.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 47 | 48 | $3,441 | $3,361 | 97.7% |
About Dr. Keith Ratzlaff, MD
Dr. Keith Ratzlaff, MD is a Family Medicine healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770536880.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Ratzlaff, MD has received a total of $4,512 in payments from pharmaceutical and medical device companies, with $33.84 received in 2024. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,200).
As a Medicare-enrolled provider, Ratzlaff has provided services to 4,367 Medicare beneficiaries, totaling 6,055 services with total Medicare billing of $262,156. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Olathe, KS
- Active Since 05/18/2006
- Last Updated 09/22/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1770536880
Products in Payments
- Prolia (Biological) $4,325
- UBRELVY (Drug) $37.11
- VOQUEZNA (Drug) $17.90
- PREVNAR 20 (Biological) $12.01
- Saxenda (Drug) $10.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olathe
Constance Irick, M.d, M.D
Family Medicine — Payments: $21,543
Family Medicine $21,543
Travis Keller, Md, MD
Family Medicine — Payments: $13,363
Family Medicine $13,363
Dr. Fred Church, D.o, D.O
Family Medicine — Payments: $13,106
Family Medicine $13,106
Dr. Holly Kaufman, M.d, M.D
Family Medicine — Payments: $12,247
Family Medicine $12,247
Dr. Anthony Justesen, Md, MD
Family Medicine — Payments: $5,767
Family Medicine $5,767
Dr. Young Cho, M.d, M.D
Family Medicine — Payments: $5,229
Family Medicine $5,229